Previewing the 2024 ASGCT Annual Meeting in Baltimore with gene editing expert TJ Cradick

A computational biologist and assistant professor at Philadelphia’s Wistar Institute on positives and potential negatives of AI’s emergence to the forefront of life sciences

Founder Mark Kotter describes the science that has enabled bit.bio to design and manufacture virtually any cell type and characteristic from iPSCs

How Cambridge Innovation Capital has become a preeminent investment firm in Cambridge life sciences, and also a significant attractor of outside capital to Cambridge

Innovate Cambridge's new executive director shares an overview of the key points and institutions to know within Cambridge life sciences

How The Milner Therapeutics Institute at University of Cambridge plays key roles in the life sciences ecosystem